{"entity":{"type":"insider","cik":"0001586745","url":"/insider/0001586745","json_url":"/insider/0001586745.json","name":"Knopf John L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":67,"n_filings":21,"first":"2014-05-21","last":"2016-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Knopf John L","source":"filing","n_filings":21,"first_seen":"2014-05-21","last_seen":"2016-11-14"}],"transactions":[{"id":2042336,"accession":"0001179110-16-031541","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-16-031541","line_url":"/filing/0001179110-16-031541#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":32.19,"price_display":"32.19","price_state":"stated","total_value":3219000.0,"total_display":"3,219,000.00","total_whole":"3,219,000","shares_owned_after":214084.0,"shares_owned_after_display":"214,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-14","scope":"insider"},{"id":2174320,"accession":"0001179110-16-027490","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-16-027490","line_url":"/filing/0001179110-16-027490","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41477.0,"shares_display":"41,477","price_per_share":33.75111073607059,"price_display":"33.75","price_state":"stated","total_value":1399894.82,"total_display":"1,399,894.82","total_whole":"1,399,895","shares_owned_after":129521.0,"shares_owned_after_display":"129,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-06","filed_date":"2016-07-06","scope":"insider","n_lines":2},{"id":2174311,"accession":"0001179110-16-027490","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-16-027490","line_url":"/filing/0001179110-16-027490","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30501.0,"shares_display":"30,501","price_per_share":33.26149241008491,"price_display":"33.26","price_state":"stated","total_value":1014508.78,"total_display":"1,014,508.78","total_whole":"1,014,509","shares_owned_after":121474.0,"shares_owned_after_display":"121,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-05","filed_date":"2016-07-06","scope":"insider","n_lines":2},{"id":2174303,"accession":"0001179110-16-027490","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-16-027490","line_url":"/filing/0001179110-16-027490","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28022.0,"shares_display":"28,022","price_per_share":34.72468774534295,"price_display":"34.72","price_state":"stated","total_value":973055.2,"total_display":"973,055.20","total_whole":"973,055","shares_owned_after":119084.0,"shares_owned_after_display":"119,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-06","scope":"insider","n_lines":2},{"id":2949003,"accession":"0001179110-16-025240","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-16-025240","line_url":"/filing/0001179110-16-025240#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25787.0,"shares_display":"25,787","price_per_share":33.17,"price_display":"33.17","price_state":"stated","total_value":855354.79,"total_display":"855,354.79","total_whole":"855,355","shares_owned_after":124084.0,"shares_owned_after_display":"124,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-20","scope":"insider"},{"id":2948993,"accession":"0001179110-16-025240","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-16-025240","line_url":"/filing/0001179110-16-025240#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37623.0,"shares_display":"37,623","price_per_share":33.04,"price_display":"33.04","price_state":"stated","total_value":1243063.92,"total_display":"1,243,063.92","total_whole":"1,243,064","shares_owned_after":124084.0,"shares_owned_after_display":"124,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-19","filed_date":"2016-05-20","scope":"insider"},{"id":2948979,"accession":"0001179110-16-025240","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-16-025240","line_url":"/filing/0001179110-16-025240#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36590.0,"shares_display":"36,590","price_per_share":33.04,"price_display":"33.04","price_state":"stated","total_value":1208933.6,"total_display":"1,208,933.60","total_whole":"1,208,934","shares_owned_after":124084.0,"shares_owned_after_display":"124,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-20","scope":"insider"},{"id":8529768,"accession":"0001179110-15-013969","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-013969","line_url":"/filing/0001179110-15-013969","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19000.0,"shares_display":"19,000","price_per_share":24.38356,"price_display":"24.38","price_state":"stated","total_value":463287.64,"total_display":"463,287.64","total_whole":"463,288","shares_owned_after":119084.0,"shares_owned_after_display":"119,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-07","filed_date":"2015-10-09","scope":"insider","n_lines":2},{"id":8801262,"accession":"0001179110-15-013211","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-15-013211","line_url":"/filing/0001179110-15-013211","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19000.0,"shares_display":"19,000","price_per_share":30.204725263157894,"price_display":"30.20","price_state":"stated","total_value":573889.78,"total_display":"573,889.78","total_whole":"573,890","shares_owned_after":26757.0,"shares_owned_after_display":"26,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-08","filed_date":"2015-09-10","scope":"insider","n_lines":3},{"id":8570348,"accession":"0001179110-15-012049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-012049","line_url":"/filing/0001179110-15-012049","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19000.0,"shares_display":"19,000","price_per_share":28.528684210526315,"price_display":"28.53","price_state":"stated","total_value":542045.0,"total_display":"542,045.00","total_whole":"542,045","shares_owned_after":22084.0,"shares_owned_after_display":"22,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-10","filed_date":"2015-08-12","scope":"insider","n_lines":2},{"id":8823196,"accession":"0001179110-15-011074","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-15-011074","line_url":"/filing/0001179110-15-011074","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19000.0,"shares_display":"19,000","price_per_share":29.703473684210525,"price_display":"29.70","price_state":"stated","total_value":564366.0,"total_display":"564,366.00","total_whole":"564,366","shares_owned_after":18984.0,"shares_owned_after_display":"18,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-07","filed_date":"2015-07-09","scope":"insider","n_lines":2},{"id":8056457,"accession":"0001179110-15-009439","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-009439","line_url":"/filing/0001179110-15-009439","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19000.0,"shares_display":"19,000","price_per_share":32.513894736842104,"price_display":"32.51","price_state":"stated","total_value":617764.0,"total_display":"617,764.00","total_whole":"617,764","shares_owned_after":18184.0,"shares_owned_after_display":"18,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-09","scope":"insider","n_lines":2},{"id":8657937,"accession":"0001179110-15-007709","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-15-007709","line_url":"/filing/0001179110-15-007709","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":31.79565,"price_display":"31.80","price_state":"stated","total_value":635913.0,"total_display":"635,913.00","total_whole":"635,913","shares_owned_after":13484.0,"shares_owned_after_display":"13,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-11","filed_date":"2015-05-13","scope":"insider","n_lines":2},{"id":8810440,"accession":"0001179110-15-006142","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001179110-15-006142","line_url":"/filing/0001179110-15-006142","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":34.8742,"price_display":"34.87","price_state":"stated","total_value":697484.0,"total_display":"697,484.00","total_whole":"697,484","shares_owned_after":14684.0,"shares_owned_after_display":"14,684","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-07","filed_date":"2015-04-08","scope":"insider","n_lines":6},{"id":8631578,"accession":"0001179110-15-004582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-004582","line_url":"/filing/0001179110-15-004582","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.247539,"price_display":"40.25","price_state":"stated","total_value":804950.78,"total_display":"804,950.78","total_whole":"804,951","shares_owned_after":30085.0,"shares_owned_after_display":"30,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-09","filed_date":"2015-03-10","scope":"insider","n_lines":2},{"id":8072423,"accession":"0001179110-15-002311","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-002311","line_url":"/filing/0001179110-15-002311","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":36.6490785,"price_display":"36.65","price_state":"stated","total_value":732981.57,"total_display":"732,981.57","total_whole":"732,982","shares_owned_after":49521.0,"shares_owned_after_display":"49,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-11","scope":"insider","n_lines":2},{"id":8062779,"accession":"0001179110-15-000771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-000771","line_url":"/filing/0001179110-15-000771","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":39.6162,"price_display":"39.62","price_state":"stated","total_value":792324.0,"total_display":"792,324.00","total_whole":"792,324","shares_owned_after":56500.0,"shares_owned_after_display":"56,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-07","filed_date":"2015-01-09","scope":"insider","n_lines":2},{"id":6640256,"accession":"0001179110-14-017790","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-14-017790","line_url":"/filing/0001179110-14-017790","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":43.9943125,"price_display":"43.99","price_state":"stated","total_value":879886.25,"total_display":"879,886.25","total_whole":"879,886","shares_owned_after":82451.0,"shares_owned_after_display":"82,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-08","filed_date":"2014-12-09","scope":"insider","n_lines":8},{"id":6904352,"accession":"0001179110-14-016614","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-016614","line_url":"/filing/0001179110-14-016614","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":33.03995,"price_display":"33.04","price_state":"stated","total_value":660799.0,"total_display":"660,799.00","total_whole":"660,799","shares_owned_after":105899.0,"shares_owned_after_display":"105,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-14","scope":"insider","n_lines":2},{"id":6175362,"accession":"0001179110-14-015328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-015328","line_url":"/filing/0001179110-14-015328#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.2,"price_display":"30.20","price_state":"stated","total_value":302000.0,"total_display":"302,000.00","total_whole":"302,000","shares_owned_after":116500.0,"shares_owned_after_display":"116,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-08","filed_date":"2014-10-09","scope":"insider"},{"id":6175360,"accession":"0001179110-14-015328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-015328","line_url":"/filing/0001179110-14-015328#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":29.22,"price_display":"29.22","price_state":"stated","total_value":292200.0,"total_display":"292,200.00","total_whole":"292,200","shares_owned_after":126500.0,"shares_owned_after_display":"126,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-07","filed_date":"2014-10-09","scope":"insider"},{"id":6489108,"accession":"0001179110-14-014073","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-14-014073","line_url":"/filing/0001179110-14-014073#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6447.0,"shares_display":"6,447","price_per_share":24.21,"price_display":"24.21","price_state":"stated","total_value":156081.87,"total_display":"156,081.87","total_whole":"156,082","shares_owned_after":136720.0,"shares_owned_after_display":"136,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-09","filed_date":"2014-09-10","scope":"insider"},{"id":6489106,"accession":"0001179110-14-014073","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-14-014073","line_url":"/filing/0001179110-14-014073#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6406.0,"shares_display":"6,406","price_per_share":24.21,"price_display":"24.21","price_state":"stated","total_value":155089.26,"total_display":"155,089.26","total_whole":"155,089","shares_owned_after":143394.0,"shares_owned_after_display":"143,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-09","filed_date":"2014-09-10","scope":"insider"},{"id":6489104,"accession":"0001179110-14-014073","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-14-014073","line_url":"/filing/0001179110-14-014073#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001586745","owner_name":"Knopf John L","owner_display_name":"Knopf John L","owner_url":"/insider/0001586745","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":227.0,"shares_display":"227","price_per_share":24.71,"price_display":"24.71","price_state":"stated","total_value":5609.17,"total_display":"5,609.17","total_whole":"5,609","shares_owned_after":143167.0,"shares_owned_after_display":"143,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-09","filed_date":"2014-09-10","scope":"insider"}],"collapsed":true,"next_cursor":"2014-09-09|6489104","ledger_fault":false,"count":{"value":67,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":67,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":67},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001280600","name":"ACCELERON PHARMA INC","url":"/issuer/0001280600","role":"Director, Officer (CEO and President)","n_filings":21,"first_seen":"2014-05-21","last_seen":"2016-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001586745","retrieved_at":"2026-08-22T10:54:38+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}